Skye Bioscience, Inc. (SKYE)
1.15
+0.01
(+0.88%)
USD |
NASDAQ |
Dec 11, 11:08
Skye Bioscience Price: 1.15 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.56 |
| Theravance Biopharma, Inc. | 17.49 |
| Viking Therapeutics, Inc. | 37.47 |
| FibroGen, Inc. | 8.82 |
| Myomo, Inc. | 1.07 |
Price Related Metrics
| PEG Ratio | -0.0167 |
| Price to Book Value | 1.123 |
| Earnings Yield | -112.2% |
| Market Cap | 36.87M |
| PEGY Ratio | -0.0167 |